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ABSTRACT 
A comparative study was undertaken in rats, rabbits, miniature swine and man, in which 
the percutaneous absorption of the following compounds, labeled with "C or 358, were 
studied: haloprogin, N-acetylcysteine, cortisone, testosterone, caffeine and butter yellow. 
The amount of radioactivity exc reted in urine for 5 days following a pplication of the test 
compound to the skin was e mployed as the index for quantifying skin penetration. A 
s pecial nonocclusive foam pad devi ce for rabbits a nd miniature swine was developed to 
prevent artifacts resulting from transfer of drug to the urine by any route other than percu-
taneous absorption. The dose was 4 J.Lg/c m 2 of skin surface. The excretion data obtained 
from the topical studies were adjusted for recove ry of radioactivity following intravenous 
administration of the radioactive drug. The results obtained in this study indicated that 
skin permeability decreases in the following order: rabbit, ra t, pig a nd man. Overall , skin of 
miniature swine has the closest permeability characteristics to tha t of human skin with this 
series of compounds. 
During the toxicological evaluation of a new 
drug, animal species resembling man in the 
fashion in which the drug is absorbed and meta b-
olized should be utilized. The skin of pig, guinea 
pig, rat and ra bbit were, in that order, increas-
ingly more permeable than human skin in vitro to 
not only ionic a nd convalent substances in 
aqueous solution but organic solutes as we ll ( 1) . 
Marzulli et al. (2) observed that in s kin penetra-
tion studies involving classifie'd chemical warfa re 
agents of undisclosed structure, the back skin of 
weanling pigs approximated human forearm skin 
in its permeability characteristics. However, re-
garding topical agents of therapeutic value, there 
are few data available with which to compare the 
permeability of animal and human s kin in vivo. 
Methods for measuring percu taneous penetra-
tion have been reviewed by Malkinson and 
Rothman (3). The purpose of the present study 
was to compare the percutaneous a bsorption in 
vivo of s ix test compounds in rats , rabbits, minia-
ture swine, and man. The methodology was pat-
terned after the procedure developed by Feld-
mann and Maibach (4) for measurement of percu-
taneous absorption in man. This method involves 
quantifying absorption on the basis of the percent 
of radioactivity excreted in urine fo r five days fol-
lowing a pplication of a known a mount of the la -
beled compound to the skin. To correct for excre-
tion of radioactivity by other routes and retention 
of radioactivity in the body, urinary exc retion 
data obtained after dermal application of the 
compound are adjusted in accorda nce with the 
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urinary excretion observed a fter intravenous 
dosage. 
MATERIALS AND METHODS 
Haloprogin -''C, 1-iodo-3-(2 , 4, 5-trichlorophenoxyl)-1 -
propyne, was randomly labeled in the benzene ring and 
had a specifi c activity of 0.4 mCi/mM. N-acetylcysteine 
was labeled with sulfur-35 and had a specific act ivity of 
0.7 mCi/ mM . Cortisone-4- "C, 45 mCi/m M; testoster-
one, 40 mCi/mM; caffeine-1- methyl- "C, 6 mCi/ mM, 
and p-dim ethylaminoazobenzene-"C (but ter ye ll ow) , 
2.5 mCi/mM, were obtained from New England Nuclear 
Corporat ion. 
Partition coefficients for each drug were determined 
as follows: A given amount of drug was dissolved in 
polyethylene glycol 400 and triplicate 0.1 ml-aliquots of 
this solution were added to 5 ml of 0.1M phosphate 
buffer, pH 7.4. Each solution was equilibrated with 5 ml 
of heptane by shaking for 30 minutes at room tempera-
ture. Following centr ifugat ion, the concentration of drug 
in the aqueous and hepta ne phases was dete rmined by 
liquid scintillation counting. Partition coefficients are 
expressed in terms of concentration of drug in heptane 
divided by concentration of drug in buffer. 
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Sprague-Dawley rats, New Zealand white rabbi ts, 
and miniature swine' of the Pitman -Moore Improved 
strain (2- 3 months of age) were used in these studies. 
For intravenous injection the compounds were dissolved 
in polyethylene glycol 400, and when the test materials 
were ad ministered topically the vehicle was acetone. 
Animals were maintained in individual , stainless steel 
metabolism cages. Food and water were permitted ad 
libitum. Urine was collected at 24-hour intervals for 5 
days following drug administrat ion. 
For topical application to rats the foll owing proce-
dures were carried out with the animals under ether 
anesthesia. On the day before drug application , the hair 
on the dorsal, mid -lumbar region was removed wi th 
small animal clippers equipped with a No. 40 head . 
Immediately before dosing, a restra ining harness-and-
collar assembly of one inch adhesive tape and 0.25"-
bore vacuum tubing was placed around the trunk of the 
animal posterior to the front legs. A metal ring en-
closing an area of 10 cm 2 and coated with petrolatum 
jelly was used to demarcate the dosed area and to aid in 
con!inin g the compound to the desired site (4). By 
'Vita Vet Laboratories, Marion, Indiana . 
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FIG. 1. Exploded diagram of non-occlusive foam pad device used on rabbits and miniature swine. 
means of a 0.5-ml sy ringe wi th blunt needle, 4 llg/cm 2 
of the test compound was appli ed to the back. The an-
imal was placed in the metabolism cage and the harness 
fastened to the center of the ca ge top wi th a short steel 
tube held in place wi th a Flexaframe' connector. Thus 
the rat was permit ted to pivot in the center of the cage 
but could not lick or wipe off the compound, nor rub it 
off on the cage walls . 
Hair on the dorsal , midlumbar region was removed 
with clippers one day prior to topical dosing of rabbi ts 
and miniature swine. The stubble remaining on t he 
backs of pigs were removed with a commercially ava il -
able depilatory. 3 The a reas of a pplication were 20 em 2 
fo r rabbits and 50 em' for miniature swine. A protective 
device, pictured in Figure 1, was developed fo r pre-
venting loss of the material from the backs of these 
a nimals. Its design and method of securing it to the 
an imal were as follows. Immediately before drug appli -
cation a rectangula r piece of Yi 6 inch self-adhering foam 
padding,' with a smaller rectangula r portion removed 
fro m tlie middle, was affixed to the back of the animal. 
The area of application was demarcated as described 
a bove. Depending upon the volume of solut ion to be 
applied, a one- or two- ml syringe with a blunt needle 
was employed to dispense 4 llg/cm 2 of the test com-
pound. Following application of the material and evapo-
ration of the acetone vehicle, a second layer of foa m 
padding with wire sc reen fastened to the top was placed 
on top of the fi rst pad. A gauze pad was taped over the 
top of the screen to prevent dried stratum corneum 
from fa lling in to the metabolism cage. T o insure that 
t he protective padding remained in place, adhesive tape 
was wra pped around the t runk of the animal over the 
front and rear port ions of the protective device, leaving 
the dosed area exposed to the atmosphere. A minia ture 
swine with the non-occlusive protective device in place 
is shown in Figure 2. 
Application of haloprogin and N-acetylcysteine to 
human skin was performed according to the method of 
2 F lexaframe®, Fisher Scient ific Company, Pi tts-
burgh, P ennsylvania. 
3 Nair®, Carter Products, Division of Carter-Wallace, 
Inc., New York, New York. 
'Reston®, Medical Products Division, 3M Company, 
St. Paul , Minnesota. 
F eldmann and Maibach (4). Data for the r emaining test 
compounds were taken from the work of Feldmann and 
Maibach (4, 5). The anatomic site was th e vent ral sur-
face of the forearm and in all experiments the amount 
of material applied was 4 llg/c m 2 • 
For radioactivity assay, a 0.3 ml aliquot of each urine 
sample from the ra t, rabbit, and swine studies was 
placed in a count in g vial to which was added 0.6 ml of 
water. Fifteen ml of scint illator solution (5.0 g 2, 5-di -
phenyloxazole, 0.5 g p-bis-(0- methylstyryl) -benzene, 
120 g naphthalene plus dioxane to give on e li ter of solu-
tion) was added to each sample. Afte r adequate cooling, 
the sa mples were counted in a Pac kard Tri -Carb Model 
3375 liquid scint illation spectrometer with automatic 
external standardi za tion. Analysis of huma n urine spec-
imens was ca rried out according to a wet ash procedure 
described by Feldmann and Maibach (4) prior to liquid 
scintillation coun ting. 
The percent of applied dose recovered in each urine 
coll ection, when divided by the percen t of dose re-
covered in urine afte r in travenous administrat ion, was 
used to provide an estimate of the total amount ab-
sorbed through the skin for each part icular period of 
t im e. For comparison of the relative ra te of absorpt ion 
the logarithm of the percent of dose not absorbed was 
plotted versus time. 
RESULTS 
T a ble I sho ws t h e total recovery of ra di oactivity 
in urine of rats , rabbits, miniature swine, and 
man a fter in t raven ous a dminis tra tio n of t h e s ix 
t es t compounds. In all cases at least 80% of t h e 
tota l ra dioactivi ty exc reted in the urin e was 
found durin g t he firs t 24 hours after administra-
ti on of t he compound. 
T a ble II con tains the d a ta ob taine d a fte r top-
ica l administration of t h ese compounds to t he 
four anima l species. 
Urine collections were ma d e on ce every 24 
hours following appli cation of t he test compounds 
to the back s kin of rats, rabbits a nd miniature 
s win e whereas, in t h e huma n studies , urine speci-
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FIG. 2. Foa m pad device a ffixed to back of miniature swine. 
TABLE 1 
Recovery of radioactivity iri urine following intravenous administration 
Percent recovery in urine within fiv e days 
Rat. Rabbit Pig Mnn 
Compound Number Totul N umber Total Number To lu i Number To lu i S. D. 
tested percent S.D. tested percent S.D. tested percent S.D. tested percen t. 
Haloprogin - ••c 7 96.2 ± 15.6 3 81.7 ± 17.9 2 77.1 ± 4.24 3 75.4 ± 6.4 
N -Acetylcysteine-"8 4 30.5 ± 2.75 3 14.1 ± 1.73 2 7.8 ± 2.12 3 57. 2 ± 18.0 
Testosterone- " C 4 32.0 ± 14.7 3 90. 2 ± 11.9 2 89.3 ± 12.7 92.1 ** 
Cortisone- " C 4 35.4 ± 8.06 3 109.1 ± 1.73 2 77.2 ± 2.01 65.4** 
Caffeine- ••c 4 74.0 ± 4.50 3 75.6 ± 4.04 2 75.4 ± 3.53 59.4** 
Butter Yellow- "C 4 100.0 ± 9.10 3 66.7 ± 9.54 2 74.8 ± 6.36 - * 
• Test compound was admin istered in travenously to guinea pigs because it was too toxic to inject i.v. in man. A 
value of 58.6%, obtained from guinea pigs, was used to correct the recovery foll owing topical admin istrat ion in 
humans. 
** Taken from Feldmann, R. J. a nd Maibach, H . I.: J. Invest. Derm., 54: 399, 1970. Ibid. , 52: 89, 1969. 
mens were collected at several t ime intervals 
during the first day . In Figures 3- 7 the human 
data have been recalculated on a 24 hour basis for 
comparison with the animal data . 
Haloprogin was readily absorbed t hrough rat 
and rabbit skin . As shown in Figure 3, penetra-
tion of this compound through the skin of pigs 
and man was quite similar and much slower than 
it was through rat and rabbit skin. The total ab-
sorption of this drug was less in pigs and man 
than it was in rats and rabb its . 
N-acetylcysteine was a minimal penetrant in 
all species studied and hence, penetration rates 
were not plotted graphically. Because of the low 
specific activity of the labeled compound, the 
limit of sensitivity for measuring total absorption 
in miniature swine was approximately 6 percent 
of the applied dose. 
The penetration rates for testosterone are given 
in Figure 4. As with haloprogin, rat and rabbi t 
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TABLE IT 
Recovery of radioactivity in urine follow ing topical administration 
Percent • of npplicd do~e/rla _,. T otnl ab!'o rpt ion 
Number Pcnetru nl tes ted Percent .. Dny I Dny 2 Ouy :1 On·y ·I Day !l ofdo!'e S.D. 
Haloprogin 
Rat 4 58.2 25 .5 7.03 3.35 1.62 95.8 13.9 
Rabbi t 3 55.9 35.0 14.6 5.75 7.96 113.0 16. 5 
Pig 2 5.83 5.83 3.64 1.42 1.42 19.7 9.92 
Man 6 6.48 2.29 1.11 0.70 0.44 11.0 3.74 
N-Acetylcysteine 
Rat 4 0.66 0.59 0.59 0.53 1.16 3.50 3.77 
Rabbit 3 1.98 0.48 0.48 0.48 0.48 1.98 0.95 
P ig 2 1.20 1.20 1.20 1.20 1.20 6.00 -
Man 6 0.40 0.43 0. 33 0.66 0.59 2.43 1.57 
Testosterone 
Rat 4 12.1 15.2 10.2 6.06 3.78 47.4 2.62 
Rabbi t 3 34.52 19.7 7.07 5.12 3.23 69 .6 7.81 
Pig 2 9.42 8.25 3.47 3.73 4.48 29.4 8.55 
Ma n ** 17 6. 13 3.74 1.58 0.86 0.4 3 13.2 3.04 
Cortisone 
Rat 4 6.30 6.47 4.49 3.59 3.87 24.7 3.62 
Rabbi t 3 5.17 9.26 6.64 5. 17 4.02 30. 3 9.03 
Pig 2 0.54 0.76 1.68 0.60 0.48 4.06 1.58 
M a n .. 7 0.62 0.94 0.86 0.77 0.58 3.38 1.64 
Caffeine 
Rat 4 27.0 10. 1 7.55 5.05 3.49 53.1 11.8 
Rabbi t 3 25 .3 24.3 11.6 5.28 2.83 69 .2 5.82 
Pig 2 14.3 10.2 4.16 2.24 1.47 32.4 4.82 
Man .. 12 23 .3 20.5 2.62 0.77 0.34 47.6 20.9 
B utte r Yell ow 
Rat 4 27.8 12.0 4.62 2.17 1.63 48.2 2.17 
Rabbit 3 81.7 7.53 4.06 4.23 2.50 100.0 7.90 
P ig 2 10.1 21.9 6.19 2.23 1.40 41.9 10.0 
Man .. 4 10.8 6.94 1.99 1.30 0.53 21.6 4.88 
* Corrected for recovery fo llowing pa rentera l administration. 
** Human data taken from Feldma nn, R. J. and Maibach, H . L. : J. Invest. Derm ., 52: 89, 1969. Ibid. , 54: 399, 
1970. 
skin were qui te permeable to thi s compound . The 
a ppa rent penetration rates t h rough pig a nd 
human skin were comparable after testosterone 
administration and, with a ll spec ies stud ied, ab-
sorpt ion was more rapid during the first two days 
after drug application than during the remaining 
three days . 
Cort isone was a minimal penetrant through the 
skin of man and miniature swine, the penetration 
rates in these two species we re s imilar (Figure 5). 
Once aga in, rat and ra bbi t skin were qui te perme-
able to th e test compound. 
Caffeine penetrated rat and rabbit skin quite 
readily as shown in Figure 6. The s kin of swine 
a nd man offered a slight ly more effective barri er 
to ent ry of t his test materia l bu t, because of t he 
variabili ty in the human skin p enetrat ion studies 
(T a ble II) , t he differences obse rve d between 
human and pig s kin permeabili ty a re not statisti-
cally sign ifican t. In the latter two animal spec ies, 
absorp tion was considerab ly faster during the first 
48 hours than during the remaining 72 hours. 
The absorption data for butte r yellow are given 
in Figure 7. T his compound penetrated rabbit 
skin much mo re ra pidly than it did th rough the 
skin of the remai ning t hree animal spec ies, and 
wi th rabbit sk in pen etration was relatively con-
stant t hroughout the t ime of t he experi ment. T he 
a pparen t penetration rates through rat, p ig and 
human skin decreased wi t h t ime fo llowing drug 
a pplication . 
T he data on total absorption, summari zed in 
Figure 8, de monstrate t hat skin permeabi li ty in -
creased in the fo llowing order: man, p ig, rat and 
ra bbi t, i. e., t he pig had skin with pe rmeab il ity 
cha racteristics closest to that of man with t hi s 
series of compounds. 
Pa rt it ion coefficients obtai ned by distribut ion 
of t he test compounds between heptane and pH 
7.4 buffe r a re listed in Table III. In this series of 
com pounds a good correlation was found between 
magnitude of part it ion coeffi cient and s kin pene-
tration wi th th e exce pt ion of ca ffe in e which 
readi ly penetrated the skin despi te its low parti-
t ion coefficient. Essen t ia lly the sa me partition 
coefficien ts were obta ined whether pH 7.4 buffer 
or dist ill ed water were used as the aqueous 
phase . 
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FIG. 3. Percutaneous absorption of haloprogin in rats, rabbits, miniature swine and man for 5 days after applica-
tion. 
DISCUSSION 
Four of the test materials used in this study 
were the sa me as those compounds investigated 
by Feldmann and Maibach (4, 5) which, in human 
skin studies, ran the gam ut from minimal to 
maxima l penetrability. The rema ining com-
pounds, haloprogin and N-acetylcysteine, were 
undergoing toxicologica l evaluat ion in our labora-
tories. 
The method used in this study for quantifying 
percutaneous absorption is on ly approximate. It 
assumes that excretion and t issue distribution of 
the test compound after percutaneous absorption 
is the same as after intravenous injection. Al-
though this assump tion is useful as a basis for 
numerical comparison, it has not been proven for 
the compounds tested . Detailed studies on t he 
comparative disposition of drugs following percu-
taneous and in travenous dosage, while of poten-
tial interest, are beyond the scope of the present 
work and are impractical in a screening proce-
dure. 
T he shape of the absorption curves shown in 
Figures 3- 7 suggest that under the conditions 
used in these studies, absorption is genera lly not 
a simple first order process. With some excep-
tions the apparent rate of absorption was highest 
ini t ia lly and then decreased at later time periods. 
In the case of t he human studies thi s could be 
explained by the fact that the subjects were al-
lowed to wash t he absorption site at any time 
after the first 24 hours following drug administra-
tion. In the animal studies, however, the skin was 
undisturbed for t he entire . experimental period. 
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F lG. 4. Percutaneous absorption of testosterone in rats, rabbi ts, miniature swine and man for 5 days after appli -
cation. 
An explanation of the decrease in apparent rate 
of absorption and d efini t ion of the pha rmaco ki -
netic mechani sms cont rolling the percutaneous 
absorption process in vivo will require addi t iona l 
studies. 
Feldmann a nd Ma ibac h (6) studied regional 
va riation in percuta neous penetration of ' 'C-hy-
drocortisone in man and observed tha t bac k skin 
was 1.7 t imes more permeable than forearm skin . 
The comparisons described in the presen t report 
were based on absorpt ion data from fo rea rm s kin 
in humans and bac k skin in animals. If a bsorp-
t ion data from human bac k skin were ava ilable 
fo r comparison, an even greater s imila rity in pen-
etrat ion of severa l of t he test compounds (ha lo-
progin , testosterone and butte r yellow) in man 
a nd swin e might be observed. 
Previous workers have investigated the so lubili -
t ies of compounds in relation to t heir abili ty to 
p enet ra t e skin and have fo und tha t as t he 
ether/wate r pa rt it ion coeffi cient increases, percu-
taneous absorpt ion is enhanced (7 , 8). With t he 
exception of caffeine, our resul ts support t hese 
earlier findings. However, Stoughton et al . (7) and 
Katz and Sha ikh (9) have suggested that ease of 
penet ration is also dependent upon the absolute 
aqueous and lipid so lubili t ies of t he compound in 
q uestion, and caffeine is hi ghly solubl e in organic 
solvents such as chloroform as well as in water. 
Factors other t ha n species differe nce which 
might affect t he pen etration rate of a given com-
pound a re: anatomic s ite, temperature, humidi ty, 
nature of vehicle, and the presence or a bsence of 
disease. Loss of the compound externa lly will also 
a ffect the apparent penetration ra te. Use of the 
non-occlusive foa m pad dev ice minimizes the 
latter of these facto rs. In addition, essen t ia lly 
normal condi t ions of the temperature and hu-
midity a re ma in tain ed above t he dosed area , and 
the absorpt ion process is not subject to art ifi cia l 
condi t ions which exist when an occlusive covering 
is used. This foa m pad device could not be used 
with rats because a method to prevent t he ani-
mals from removing the device could not be 
found . Although the permeabili ty characteristics 
of skin may be alte red by such pre-treatment as 
clipping the hair and re mova l of stubble with a 
depilatory, development of standard methods for 
studying skin permeabili ty in animals did not 
appear feasible unless t he ha ir was re moved. In 
prelimina ry studies with haloprogin in rats, the 
permeabili ty was the sa me whether the com-
pound was a pplied immediately after ha ir re-
moval or on t he following day. 
In this present se ri es of com pounds studied in 
vivo, the arrangement of animal spec ies in de-
creasing order of skin permeabili ty (rabbi t, rat, 
miniature swine and man) is in agreement with 
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TABLE Ill 
Partition coeffi cients of test co mpou nds in 
heptane/buffer* 
Compound 
Haloprogin 
N -Acetylcysteine 
Testosferone 
Cortisone 
· Caffeine 
Butter yellow 
* 0.1M phosphate buffer, pH 7.4. 
Part ition 
coc rticicnts 
45.4 
0.0004 
1.81 
0.002 
0.005 
100.8 
that which Tregaer (1) obta ined in his in vitro 
studies. 
Although rabbits are routinely employed in 
dermal toxicity tests, in the presen t s tudy a con-
siderable species difference was found in the pen-
etrat ion rates of various compounds t hrou gh 
rabbit and human skin. In genera l, for a single 
dermal dose, total exposure of the outer surface of 
the skin to the applied compound will be of 
shorter duration in the rabbit than in man . How-
ever , because of the higher penetration rate in the 
rabbit, temporarily higher concentrations of com -
pound might occur within the rabbit s kin as com-
pared to human skin. The time course of systemic 
exposure to the compound will also be markedly 
different in the t wo species. In con t rast, it ap-
pears that the permeability of t he s kin of minia-
ture swine is close to that of huma n s kin. For 
studies in which it is desi red to use a nima l 
dermal toxicity data for predictin g toxicity in 
huma ns, in some respects the miniature swine 
appears to be a mo re suitab le test a nima l than 
the rabbit. 
The authors are indebted to Mr. Daniel W. Ranger 
for technical ass istance. Syntheses of rad ioactive halo-
progin and radioactive N-acetylcysteine were conducted 
respectively by Mr. D. A. Owens and Mr. B. F. Kava-
naugh, Chemi cal Research, Mead Johnson Resea rch 
Center. 
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